PEMF for Groin Pain
& Adductor Strain.

June 2026 · 9 min read · Sports Medicine Protocol

What Is Groin Pain and Why Is It Difficult to Treat?

Groin pain is one of the most challenging presentations in sports medicine. The groin region hosts a complex convergence of adductor muscles, hip flexors, the inguinal canal, and pubic symphysis — and injuries in this zone are frequently misdiagnosed, undertreated, or relapsed. In the Philippines, groin pain affects athletes across football, basketball, martial arts, and long-distance running, as well as manual workers performing repetitive hip-loading tasks.

Unlike isolated soft-tissue injuries, groin pain often involves two or more overlapping pathologies simultaneously, which is why accurate classification comes before treatment. The Doha agreement (PubMed 26031643, British Journal of Sports Medicine 2015), agreed by 24 international experts from 14 countries, divides athletic groin pain into defined clinical entities (adductor-, iliopsoas-, inguinal- and pubic-related), hip-related pain, and other causes — using history and physical examination alone.

Anatomy of the Groin: Five Structures, One Region

Accurate diagnosis requires understanding the five primary contributors to groin pain:

• Adductor longus — the most commonly strained adductor; origin at pubic tubercle, high risk during explosive acceleration and direction change
• Adductor brevis and magnus — deeper muscles; less frequently isolated, but critical to powerful hip adduction in kicking sports
• Gracilis — the medial thigh component; involved in combined hip adduction and knee flexion; prone to overuse injury
• Iliopsoas (hip flexor complex) — psoas major + iliacus; strained during high-velocity hip flexion; common in runners, martial artists, and football strikers
• Pubic symphysis — fibrocartilaginous joint under chronic mechanical stress in kicking athletes; osteitis pubis is a late-stage complication of undertreated adductor strain

Groin Strain Classification: Clinical Staging Table

What Causes Groin Pain? Seven Risk Factors for Clinics to Screen

Understanding the biomechanical origin guides both treatment and recurrence prevention:

• Explosive acceleration and deceleration — adductor longus is maximally loaded at initial ground contact in sprint acceleration; one burst produces tensile stress exceeding 3× bodyweight
• Adductor-to-abductor strength imbalance — a ratio below 0.80 (adductor:abductor) is independently associated with groin strain in professional athletes
• Hip flexor fatigue — iliopsoas fatigue during prolonged distance running shifts load to adductors, creating compensatory overload
• Inadequate warm-up — cold muscle compliance is 40% lower; eccentric loading under cold conditions is the most common acute injury mechanism
• Training load spike — a greater than 10% week-on-week training load increase is the single strongest predictor of soft-tissue injury recurrence
• Previous groin injury — a history of prior adductor strain increases re-injury risk 3–5× if tissue remodeling is incomplete
• Lumbar-pelvic instability — poor core stability transfers compressive and shear forces to the pubic symphysis and adductor origins

Why Standard Rehabilitation Falls Short

Conventional physiotherapy for groin strain relies on the PRICE protocol (protection, rest, ice, compression, elevation) in the acute phase, followed by progressive strengthening. While effective for initial healing, this approach has documented limitations:

• Collagen fiber realignment is passive and undirected — scar tissue forms in disorganized patterns that are weaker than native tendon
• Pro-inflammatory cytokines (TNF-α, IL-1β) remain elevated in the peritendinous tissue for 4–8 weeks post-injury, even after clinical pain resolution
• Microcirculation in the adductor tendon is inherently poor — nutrient delivery and metabolite clearance are rate-limiting steps in healing
• Neuromuscular re-education programs take 3–6 weeks before strength ratios normalize — extending re-injury vulnerability

PEMF addresses each of these bottlenecks at the cellular level.

What PEMF Does at Tissue Level — and What That Does Not Prove

The mechanistic rationale for PEMF in soft-tissue injury rests on laboratory work. It explains why the question is worth asking; it is not clinical evidence, and none of it was produced in adductor tissue:

1. Cytokine signalling — PEMF has been shown in laboratory models to act on adenosine receptor pathways on macrophages and fibroblasts, modulating TNF-α and IL-1β. No trial has measured how this changes the duration of the inflammatory phase in a human muscle injury.
2. Tendon marker expression (ex vivo) — hamstring tendon explants from nine donors exposed to PEMF for 21 days showed increased expression of scleraxis and collagen types I and VI (PubMed 41672095, Bone & Joint Research 2026). This is an explant culture, not a patient outcome.
3. Skeletal muscle cell repair (in vitro) — human skeletal muscle cells exposed to 1.5 mT PEMF closed a scratch wound faster and increased expression of HSP70, thioredoxin and SOD2 (PubMed 38068954, 2023). A cell-culture finding, not a healing rate in an injured athlete.
4. Delayed onset muscle soreness — in a randomised, double-blind, placebo-controlled study in 30 healthy students (PubMed 24906295, Physical Therapy in Sport 2015), PEMF improved perceived soreness and electromyographic measures — but did not improve isometric peak torque. It was performed in the elbow flexors of uninjured volunteers.

The Clinical Evidence for PEMF in Soft-Tissue Injury

A PubMed search returns no clinical trial of PEMF in adductor strain, groin strain or osteitis pubis. We import this technology, and we say that plainly. Any published figure for "return to sport with PEMF" in a groin injury does not rest on a dedicated trial. What does exist, and what it shows:

• The strongest evidence for soft-tissue pain generally — a 2025 prospective multi-centre randomised trial with crossover across five orthopaedic clinics, n=91, covering muscle strains and partial tears among other conditions (PMC11914662): 36% pain reduction versus 10% with standard care (p<0.0001), and a 55% drop in medication use versus 12%. This is evidence about pain, not about time to return to sport.
• The only trial that measured return to sport is negative. In a randomised, double-blind, placebo-controlled multicentre trial (PubMed 26903214, American Journal of Sports Medicine 2016, level of evidence 1), 68 patients received PEMF or placebo after arthroscopic ankle surgery. 79% versus 80% resumed sport (p=0.95), with a median of 17 versus 16 weeks (p=0.69) — no difference. Anyone selling PEMF as an accelerator of return to sport is contradicting the one trial that tested it directly.
• Post-surgical rehabilitation — a prospective, randomised, double-blind trial in 69 patients after anterior cruciate ligament reconstruction using semitendinosus and gracilis grafts (PubMed 18385980, KSSTA 2008; 1.5 mT, 75 Hz, four hours daily for 60 days) found faster functional recovery in the active group. The gracilis is one of the adductor group — but this is post-surgical rehabilitation, not treatment of an adductor strain.

By contrast, the treatment for adductor-related groin pain that does carry randomised evidence is graded active training. In a randomised trial in The Lancet (PubMed 9989713, Hølmich et al. 1999), 68 athletes with long-standing adductor-related groin pain were assigned to active training or physiotherapy without active training. Four months after treatment ended, 23 patients in the active training group returned to sport without pain versus 4 in the physiotherapy group (odds ratio 12.7; 95% CI 3.4–47.2). For prevention, a cluster-randomised trial in 652 Norwegian footballers found the Copenhagen Adduction programme reduced the risk of groin problems by 41% (OR 0.59; 0.40–0.86; p=0.008; PubMed 29891614).

Differential Diagnosis: What Else Causes Groin Pain?

PEMF Protocol for Groin Pain: By Diagnosis and Phase

Session frequency: Acute phase 5×/week (daily); repair phase 3×/week; consolidation 2×/week. Minimum course: 8–12 sessions. Full protocol for Grade II: 16–20 sessions over 6 weeks.

PEMF vs. Conventional Groin Injury Treatments

Combining PEMF with Sports Rehabilitation

The highest-outcome protocol integrates PEMF with structured adductor strengthening and neuromuscular re-education:

• Pre-exercise PEMF (15 min): reduces peritendinous inflammation and increases tissue compliance, allowing earlier introduction of eccentric loading
• Eccentric adductor exercises (Copenhagen exercises): begin in Week 2 rather than Week 3–4 because PEMF has accelerated the inflammatory phase
• Post-exercise PEMF (20 min): clears exercise-induced CK, reduces DOMS, and drives collagen fiber alignment in the repair window
• Strength ratio monitoring: adductor-to-abductor ratio >0.80 before return to cutting/sprinting activities

The measured benchmark to work against is the criteria-based one: a median of 18 days to full team training for MRI grade 0–2 injuries, and 78 days for grade 3 (PubMed 32064292, n=81). Reaching the clinically pain-free milestone before progressing matters more than the calendar: athletes who reached it re-injured at 5% versus 21% for those who did not (p=0.048).

Philippine Market Context: Who Presents with Groin Pain?

In the Philippine sports medicine context, the primary groin pain patient segments are:

• Football and Futsal players — groin strain accounts for 8–12% of all injuries in Philippine amateur football; the season runs January–November, creating year-round demand
• Basketball players — explosive lateral movement and direction change in Filipino-style 3×3 and full-court basketball create adductor overload profiles identical to football
• Martial arts athletes — Arnis, Muay Thai, BJJ, and boxing all produce high-force hip adductor loading; groin injuries are reported in 15–20% of competitive fighters
• Manual workers — construction, dock work, and agricultural labor involving repeated hip-loading generate overuse adductor strains; a lower-profile but numerically large segment for PEMF clinics
• Return-after-injury patients — the largest segment; athletes who have sustained a groin strain once are the most motivated to invest in faster, more complete recovery to prevent recurrence

Contraindications

PEMF is contraindicated in the groin region for patients with: active pacemaker or implanted cardiac device; pregnancy; active malignancy in the treatment area; active local infection or open wound. The protocol should be modified (avoid high-intensity settings) for patients with metal implants near the pubic symphysis or hip.

Frequently Asked Questions

How soon after a groin strain can PEMF begin?

PEMF is generally applied once the acute bleeding phase has settled, at 24–48 hours, on the same reasoning used for other non-thermal modalities. No trial has measured the effect of early PEMF on the inflammatory phase duration in a groin injury, so treat the timing as clinical convention rather than a proven window — and start graded isometric loading at tolerable pain in parallel, because that is the component with randomised support.

Is PEMF effective for chronic groin pain or osteitis pubis?

This has not been tested. There is no clinical trial of PEMF in osteitis pubis, and none in chronic adductor-related groin pain. For long-standing adductor-related groin pain the intervention with randomised evidence is graded active training (Lancet 1999, odds ratio 12.7). A systematic review of randomised trials in long-standing groin pain (PubMed 37425562) found seven trials and rated the certainty of evidence low by GRADE.

Can PEMF replace physiotherapy for groin injury?

No, and the evidence is unusually clear about the direction. Graded active training is the component with randomised support for adductor-related groin pain; PEMF has none in this indication, and the one trial measuring return to sport found no difference from placebo. The defensible role for PEMF is pain and swelling reduction that lets the strengthening programme begin earlier and be tolerated better — supporting the treatment that works, not substituting for it.

Does PEMF help prevent groin strain recurrence?

There is no PEMF recurrence data in groin injury. What is established is that the Copenhagen Adduction programme reduced groin problems by 41% in a cluster-randomised trial of 652 footballers (OR 0.59), and that isometric adductor strength below 465 N was associated with a 72% higher probability of groin injury in professional players (PubMed 30856592, n=71). Prevention is a strength problem, measured with a squeeze test — not a modality problem.